Tillotts Pharma and TVM Capital form Mage Biologics to develop oral antibody therapy for ulcerative colitis
Mage Biologics to develop a monoclonal antibody targeting ulcerative colitis
Mage Biologics to develop a monoclonal antibody targeting ulcerative colitis
This transformation will enable GE HealthCare to build a strong foundation for business growth
Shivalik Rasayan Limited has issued LOA to Medicamen Biotech to use its DMF grade Bortezomib API for formulation of Bortezomib injection 3.5mg/ vial
The collaboration between CARER and Wholeleaf aims to offer an integrated approach to cancer patients, combining services and products to optimize their well-being
Evonik specializes in mid- to large-scale, later clinical phase HPAPIs
This four-day course is designed for professionals in the pharmaceutical, nutraceutical, and related industries
The 'A+' rating reflects IOL's robust business model, diversified product portfolio
Pratima takes on the role of Country Speaker in addition to her role as GM and MD of Merck Specialties in India
Subscribe To Our Newsletter & Stay Updated